Vivani Medical
VANI
28 hedge funds and large institutions have $6.72M invested in Vivani Medical in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
34% more call options, than puts
Call options by funds: $157K | Put options by funds: $117K
0.03% more ownership
Funds ownership: 10.36% → 10.39% (+0.03%)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
6% less capital invested
Capital invested by funds: $7.18M → $6.72M (-$462K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$38K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.8K |
| 4 |
LCM
Lazari Capital Management
Woodland Hills,
California
|
+$12.5K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$5.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$59K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$18K |
| 3 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$15.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
VANI Hedge Fund Activity: Q3 2024 in Review
28 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2024, worth a combined $6.72M — down 6.4% from $7.18M a quarter earlier.
Fund positioning in VANI was balanced in Q3 2024: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $83.9K. The largest seller was UBS Group, cutting an estimated $59K.
- 28 institutional investors held Vivani Medical (VANI) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $6.72M of Vivani Medical stock for Q3 2024, down 6.4% quarter-over-quarter.
- 5 funds opened new Vivani Medical positions in Q3 2024 and 5 closed out, a net change of 0 holders.
- The largest Vivani Medical buyer in Q3 2024 was Vanguard Group, an estimated $83.9K added.
- The largest Vivani Medical seller in Q3 2024 was UBS Group, an estimated $59K sold.
Based on aggregated 13F filings for Q3 2024.